ImClone Investigational Site

Ottawa, Ontario K1H 8L6

0 studies enrolling now · 3 studies all time

What they study most

Colon Cancer, Colorectal Neoplasms, Hepatocellular Carcinoma, Metastases, Neoplasm, Rectal Cancer

Studies at this site

• A Study of Ramucirumab or Icrucumab in Colorectal Cancer — Completed
• A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib — Completed
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed